Income Statement Healwell AI Inc.

Stocks

AIDX

CA42249X1006

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. Other stock markets 16:00:00 2026-06-15 EDT			5-day change	1st Jan Change
0.8400 ^CAD	+3.70%		-3.45%	-

05-08	Healwell AI Inc., Q1 2026 Earnings Call, May 08, 2026
05-07	HEALWELL Halves Its Net Loss In Q1 On Huge Surge In Sales	MT

577d305bcad1d04b0ef570.9TVdEfQa8dr-QuWVe2r1s_1CSzay5xIMyF2Eb_3pvSE.nGBvWbZeob-6cJ3UPVO00akBPF_Xylx8pRvoGJ-HhUewBChSuXPHhahwtA

Published financial data: HEALWELL AI INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	47.82M	53.22M	7.32M	38.97M	104M
Total Revenues	47.82M	53.22M	7.32M	38.97M	104M
Cost of Goods Sold, Total	32.81M	36.6M	6.06M	21.66M	46.51M
Gross Profit	15.01M	16.62M	1.26M	17.32M	57.29M
Selling General & Admin Expenses, Total	33M	29.43M	14.04M	45.08M	37.87M
Provision for Bad Debts	-	-	-	-	-
Stock-Based Compensation (IS)	-	-	-	-	12.99M
R&D Expenses	155K	8.14M	4.81M	5.8M	16.42M
Depreciation & Amortization - (IS)	-	-	-	-	2.6M
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	14.31M
Other Operating Expenses, Total	33.15M	37.57M	18.85M	50.87M	84.18M
Operating Income	-18.14M	-20.95M	-17.59M	-33.56M	-26.89M
Interest Expense, Total	-462K	-488K	-1.58M	-2.61M	-10.16M
Interest And Investment Income	109K	62K	244K	638K	572K
Net Interest Expenses	-353K	-426K	-1.34M	-1.97M	-9.59M
Income (Loss) On Equity Invest.	-	-214K	-	-	-
Currency Exchange Gains (Loss)	-	-	-	-	-2.15M
Other Non Operating Income (Expenses)	-103K	-347K	-420K	-950K	4.52M
EBT, Excl. Unusual Items	-18.6M	-21.94M	-19.35M	-36.48M	-34.12M
Merger & Related Restructuring Charges	-	-	-	-	-2.63M
Impairment of Goodwill	-	-	-5.35M	-4.51M	-
Gain (Loss) On Sale Of Investments	-	-395K	-2.31M	277K	1.2M
Gain (Loss) On Sale Of Assets	-	-	-	-	-1.42M
Asset Writedown	-	-	-5.54M	-1.1M	-
Insurance Settlements	674K	936K	774K	-	-
Other Unusual Items	1.64M	1.64M	-900K	13.53M	-2.81M
EBT, Incl. Unusual Items	-16.29M	-19.75M	-32.68M	-28.28M	-39.78M
Income Tax Expense	-747K	1.22M	-542K	-856K	-662K
Earnings From Continuing Operations	-15.54M	-20.97M	-32.14M	-27.43M	-39.12M
Earnings Of Discontinued Operations	-	-	596K	-54K	-8.54M
Net Income to Company	-15.54M	-20.97M	-31.54M	-27.48M	-47.66M
Minority Interest	-129K	-115K	-52K	1.19M	553K
Net Income - (IS)	-15.67M	-21.08M	-31.6M	-26.29M	-47.11M
Net Income to Common Incl Extra Items	-15.67M	-21.08M	-31.6M	-26.29M	-47.11M
Net Income to Common Excl. Extra Items	-15.67M	-21.08M	-32.19M	-26.24M	-38.56M
Per Share Items
Net EPS - Basic	-0.33	-0.42	-0.55	-0.19	-0.19
Basic EPS - Continuing Operations	-0.33	-0.42	-0.56	-0.19	-0.15
Basic Weighted Average Shares Outstanding	48M	50.08M	57.03M	136M	251M
Net EPS - Diluted	-0.33	-0.42	-0.55	-0.19	-0.19
Diluted EPS - Continuing Operations	-0.33	-0.42	-0.56	-0.19	-0.15
Diluted Weighted Average Shares Outstanding	48M	50.08M	57.03M	136M	251M
Normalized Basic EPS	-0.24	-0.28	-0.21	-0.16	-0.08
Normalized Diluted EPS	-0.24	-0.28	-0.21	-0.16	-0.08
Payout Ratio	-	-0.55	-	-	-
Supplemental Items
EBITDA	-17.05M	-19.47M	-16.11M	-31.42M	-20.59M
EBITA	-17.51M	-19.94M	-16.58M	-31.82M	-21.23M
EBIT	-18.14M	-20.95M	-17.59M	-33.56M	-26.89M
EBITDAR	-15.94M	-17.83M	-15.33M	-	-
Total Revenues (As Reported)	-	-	-	-	104M
Effective Tax Rate - (Ratio)	4.59	-6.16	1.66	3.03	1.66
Total Current Taxes	47K	265K	19K	357K	929K
Total Deferred Taxes	-794K	952K	-561K	-1.21M	-1.59M
Normalized Net Income	-11.75M	-13.83M	-12.14M	-21.61M	-20.77M
Interest on Long-Term Debt	466K	488K	452K	707K	4.86M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.12M	1.66M	1.28M	2.38M	8.88M
General and Administrative Expenses	18.31M	12.29M	9.06M	42.69M	28.99M
Research And Development Expense From Footnotes	155K	8.14M	4.81M	5.8M	16.42M
Net Rental Expense, Total	1.11M	1.64M	787K	-	-
Imputed Operating Lease Interest Expense	278K	403K	518K	-	-
Imputed Operating Lease Depreciation	829K	1.24M	269K	-	-
Stock-Based Comp., G&A Exp. (Total)	6.11M	3.01M	2.75M	-	-
Stock-Based Comp., Other (Total)	-	1.82M	509K	7.14M	12.99M
Total Stock-Based Compensation	6.11M	4.83M	3.26M	7.14M	12.99M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	7.14M	1.41M	19.16M	9.41M	18.63M
Total Cash And Short Term Investments	7.14M	1.41M	19.16M	9.41M	18.63M
Accounts Receivable, Total	6.87M	6.02M	1.24M	6.56M	37.92M
Other Receivables	-	-	-	-	1.32M
Total Receivables	6.87M	6.02M	1.24M	6.56M	39.23M
Prepaid Expenses	-	-	-	2.35M	6.8M
Other Current Assets, Total	2.5M	1.17M	2.35M	-	-
Total Current Assets	16.51M	8.6M	22.76M	18.33M	64.67M
Gross Property Plant And Equipment	38.63M	33.84M	17.3M	20.18M	16.85M
Accumulated Depreciation	-24.7M	-23.39M	-13.56M	-15.26M	-11.77M
Net Property Plant And Equipment	13.93M	10.44M	3.73M	4.92M	5.08M
Long-term Investments	4.54M	3.93M	410K	4.11M	8.31M
Goodwill	10.07M	10.07M	12.3M	67.14M	98.55M
Other Intangibles, Total	12.45M	11.25M	12.51M	28.3M	107M
Accounts Receivable Long-Term	1.44M	860K	249K	366K	263K
Deferred Tax Assets Long-Term	1.56M	152K	-	-	480K
Other Long-Term Assets, Total	390K	319K	1.74M	2.37M	714K
Total Assets	60.89M	45.63M	53.7M	126M	285M
Liabilities
Accounts Payable, Total	6.55M	5.54M	3.93M	4.33M	14.34M
Accrued Expenses, Total	2.58M	3.28M	1.98M	4.82M	9M
Short-term Borrowings	-	7M	-	-	-
Current Portion of Long-Term Debt	-	-	672K	1.78M	24.1M
Current Portion of Leases	3.09M	1.09M	1.01M	946K	2.29M
Current Income Taxes Payable	177K	230K	19K	373K	1.53M
Unearned Revenue Current, Total	282K	438K	335K	2.45M	15.3M
Other Current Liabilities	1.82M	1.81M	1.48M	8.61M	4.23M
Total Current Liabilities	14.49M	19.39M	9.42M	23.32M	70.77M
Long-Term Debt	-	-	14.98M	14.24M	56.37M
Long-Term Leases	11.26M	9.33M	4.26M	5.24M	3.38M
Deferred Tax Liability Non Current	2.43M	1.98M	2.02M	6.51M	3.51M
Other Non Current Liabilities	2.96M	1.44M	1.54M	2.56M	27.02M
Total Liabilities	31.14M	32.14M	32.23M	51.86M	161M
Common Stock, Total	39.79M	39.79M	67.37M	140M	250M
Additional Paid In Capital	4.81M	9.64M	12.57M	17.29M	27.73M
Retained Earnings	-16.57M	-37.65M	-69.25M	-95.22M	-152M
Comprehensive Income and Other	-	-	1.96M	1.73M	-2.26M
Total Common Equity	28.03M	11.78M	12.65M	63.89M	124M
Minority Interest	1.72M	1.72M	8.81M	9.78M	-
Total Equity	29.75M	13.49M	21.46M	73.67M	124M
Total Liabilities And Equity	60.89M	45.63M	53.7M	126M	285M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	50.08M	53.87M	113M	226M	295M
ECS Total Common Shares Outstanding	50.08M	50.08M	87.99M	169M	293M
Book Value / Share	0.56	0.24	0.14	0.38	0.42
Tangible Book Value	5.5M	-9.55M	-12.16M	-31.56M	-81.52M
Tangible Book Value Per Share	0.11	-0.19	-0.14	-0.19	-0.28
Total Debt	14.35M	17.42M	20.93M	22.2M	86.13M
Net Debt	7.2M	16.01M	1.77M	12.79M	67.49M
Debt Equivalent Oper. Leases	8.86M	13.1M	6.3M	-	-
Minority Interest, Total (Incl. Fin. Div)	1.72M	1.72M	8.81M	9.78M	-
Equity Method Investments, Total	2.52M	2.31M	-	-	3M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	7.05M	6.44M	3.58M	3.71M	1.7M
Full Time Employees	400	400	102	350	570
Accumulated Allowance for Doubtful Accounts (Supple)	195K	189K	25K	190K	3.74M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-15.67M	-21.08M	-31.6M	-26.29M	-47.11M
Depreciation & Amortization - CF	3.09M	3.22M	1.79M	1.08M	2.6M
Amortization of Goodwill and Intangible Assets - (CF)	630K	1.01M	1.01M	1.73M	5.67M
Depreciation & Amortization, Total	3.72M	4.23M	2.8M	2.82M	8.26M
Amortization of Deferred Charges, Total - (CF)	585K	1.05M	1.86M	4.48M	8.64M
(Gain) Loss From Sale Of Asset	-	48K	-	-	1.42M
(Gain) Loss on Sale of Investments - (CF)	-	395K	2.31M	-277K	-1.2M
Asset Writedown & Restructuring Costs	-	-	10.9M	5.62M	-
(Income) Loss On Equity Investments - (CF)	-	214K	-	-	-
Stock-Based Compensation (CF)	6.11M	4.83M	3.26M	7.14M	12.99M
Provision and Write-off of Bad Debts	696K	63K	11K	12K	-750K
Net Cash From Discontinued Operations	-	-	-2.68M	19K	74K
Other Operating Activities, Total	-896K	32K	1.28M	-13.31M	15.42M
Change In Accounts Receivable	-1.5M	695K	4.51M	1.08M	3.3M
Change In Accounts Payable	1.11M	-368K	-3.5M	-1.65M	-9.11M
Change in Unearned Revenues	-	156K	-	-1.38M	-5.6M
Change in Other Net Operating Assets	-1.25M	1.4M	52K	-874K	-5.77M
Cash from Operations	-7.1M	-8.35M	-10.8M	-22.62M	-19.42M
Capital Expenditure	-833K	-312K	-66K	-91K	-737K
Sale of Property, Plant, and Equipment	-	-	-	-	39K
Cash Acquisitions	-5.47M	-	-1.14M	-10.63M	-71.9M
Divestitures	-	-	2.5M	-	7.41M
Sale (Purchase) of Intangible assets	-1.54M	-856K	-	-1.22M	-3.73M
Investment in Marketable and Equity Securities, Total	-810K	-	-410K	-3.43M	-
Other Investing Activities, Total	-	-	473K	-	-919K
Cash from Investing	-8.64M	-1.17M	1.35M	-15.37M	-69.84M
Short Term Debt Issued, Total	-	6.79M	3.27M	-	-
Long-Term Debt Issued, Total	498K	604K	168K	774K	76.82M
Total Debt Issued	498K	7.39M	3.44M	774K	76.82M
Short Term Debt Repaid, Total	-1.92M	-	-1.68M	-	-
Long-Term Debt Repaid, Total	-3.2M	-3.49M	-576K	-1.17M	-4.88M
Total Debt Repaid	-5.12M	-3.49M	-2.26M	-1.17M	-4.88M
Issuance of Common Stock	27.54M	-	17.45M	19.39M	32M
Repurchase of Common Stock	-870K	-	-	-625K	-
Common Dividends Paid	-	-116K	-	-	-
Common & Preferred Stock Dividends Paid	-	-116K	-	-	-
Other Financing Activities, Total	-63K	-	8.57M	9.88M	-8.43M
Cash from Financing	21.99M	3.78M	27.2M	28.24M	95.5M
Foreign Exchange Rate Adjustments	-	-	-	-	2.98M
Net Change in Cash	6.25M	-5.73M	17.75M	-9.75M	9.22M
Supplemental Items
Cash Interest Paid	-	-	-	-	5.5M
Levered Free Cash Flow	-3.65M	-2.39M	-4.1M	-1.94M	-11.06M
Unlevered Free Cash Flow	-3.36M	-2.08M	-3.11M	-310K	-4.71M
Change In Net Working Capital	76K	-2.07M	-37K	-7.53M	13.33M
Net Debt Issued / Repaid	-4.62M	3.9M	1.18M	-394K	71.93M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-27.24	-24.58	-22.14	-23.4	-8.19
Return on Total Capital	-38.19	-34.91	-30	-30.34	-10.99
Return On Equity %	-103.67	-96.99	-183.88	-57.66	-39.59
Return on Common Equity	-111.37	-105.95	-263.61	-68.57	-41.06
Margin Analysis
Gross Profit Margin %	31.39	31.23	17.18	44.43	55.19
SG&A Margin	69.01	55.29	191.85	115.66	36.48
EBITDA Margin %	-35.66	-36.58	-220.21	-80.63	-19.84
EBITA Margin %	-36.62	-37.46	-226.62	-81.65	-20.45
EBIT Margin %	-37.94	-39.36	-240.43	-86.1	-25.91
Income From Continuing Operations Margin %	-32.5	-39.4	-439.26	-70.37	-37.68
Net Income Margin %	-32.77	-39.62	-431.83	-67.47	-45.38
Net Avail. For Common Margin %	-32.77	-39.62	-439.98	-67.33	-37.15
Normalized Net Income Margin	-24.58	-25.98	-165.97	-55.45	-20.01
Levered Free Cash Flow Margin	-7.64	-4.49	-55.99	-4.98	-10.65
Unlevered Free Cash Flow Margin	-7.03	-3.92	-42.5	-0.8	-4.54
Asset Turnover
Asset Turnover	1.15	1	0.15	0.43	0.51
Fixed Assets Turnover	3.48	4.37	1.03	9.01	20.77
Receivables Turnover (Average Receivables)	8.78	8.26	2.02	9.99	4.67
Short Term Liquidity
Current Ratio	1.14	0.44	2.42	0.79	0.91
Quick Ratio	0.97	0.38	2.17	0.69	0.82
Operating Cash Flow to Current Liabilities	-0.49	-0.43	-1.15	-0.97	-0.27
Days Sales Outstanding (Average Receivables)	41.56	44.2	181.1	36.65	78.2
Average Days Payable Outstanding	61.5	60.29	285.37	69.84	73.25
Long Term Solvency
Total Debt/Equity	48.23	129.09	97.5	30.14	69.49
Total Debt / Total Capital	32.54	56.35	49.37	23.16	41
LT Debt/Equity	37.86	69.17	89.67	26.44	48.2
Long-Term Debt / Total Capital	25.54	30.19	45.4	20.31	28.44
Total Liabilities / Total Assets	51.15	70.43	60.03	41.31	56.51
EBIT / Interest Expense	-39.27	-42.93	-11.14	-12.86	-2.65
EBITDA / Interest Expense	-31.21	-34.27	-9.37	-11.78	-1.83
(EBITDA - Capex) / Interest Expense	-33.01	-34.91	-9.41	-11.81	-1.91
Total Debt / EBITDA	-1	-1.04	-1.41	-0.72	-4.62
Net Debt / EBITDA	-0.5	-0.96	-0.12	-0.42	-3.62
Total Debt / (EBITDA - Capex)	-0.94	-1.02	-1.41	-0.72	-4.45
Net Debt / (EBITDA - Capex)	-0.47	-0.94	-0.12	-0.41	-3.48
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	23.96	11.3	-29.81	432.62	426.62
Gross Profit, 1 Yr. Growth %	16.15	10.72	-66.12	1.28K	429.39
EBITDA, 1 Yr. Growth %	392.69	14.16	-3.66	104.87	-27.3
EBITA, 1 Yr. Growth %	351.31	13.86	-3.58	101.3	-26.08
EBIT, 1 Yr. Growth %	361.37	15.48	-3.39	99.52	-11.68
Earnings From Cont. Operations, 1 Yr. Growth %	1.41K	34.93	76.65	-14.67	63.29
Net Income, 1 Yr. Growth %	1.42K	34.56	49.86	-16.79	79.17
Normalized Net Income, 1 Yr. Growth %	321.68	17.64	0.98	85.34	6.09
Diluted EPS Before Extra, 1 Yr. Growth %	1.12K	28.98	54.38	-65.71	-8.36
Accounts Receivable, 1 Yr. Growth %	70.98	-12.37	-79.39	428.93	477.65
Net Property, Plant and Equip., 1 Yr. Growth %	2.65	-25.04	-64.25	31.66	3.4
Total Assets, 1 Yr. Growth %	172.34	-25.06	17.68	133.79	127.02
Tangible Book Value, 1 Yr. Growth %	-1.15K	-273.47	27.39	159.51	158.32
Common Equity, 1 Yr. Growth %	24.48K	-57.99	7.43	405.04	94
Cash From Operations, 1 Yr. Growth %	-268.12	17.58	29.38	109.47	-14.14
Capital Expenditures, 1 Yr. Growth %	880	-62.55	-77.4	37.88	709.89
Levered Free Cash Flow, 1 Yr. Growth %	-237.98	-34.54	455.23	-49.91	-7.44K
Unlevered Free Cash Flow, 1 Yr. Growth %	-213.72	-37.99	784.46	-88.2	-388.84
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.63	17.46	-60.88	93.36	276.65
Gross Profit, 2 Yr. CAGR %	45.6	13.4	-71.06	116.04	575.11
EBITDA, 2 Yr. CAGR %	285.74	137.16	-2.79	37.07	15.86
EBITA, 2 Yr. CAGR %	226.27	126.69	-2.69	36.03	15.88
EBIT, 2 Yr. CAGR %	226.96	130.83	-1.52	35.75	26.45
Earnings From Cont. Operations, 2 Yr. CAGR %	1.03K	351.87	43.81	22.77	10.32
Net Income, 2 Yr. CAGR %	1.03K	352.67	42	11.67	22.1
Normalized Net Income, 2 Yr. CAGR %	3.49K	122.73	1.65	34.06	33.47
Diluted EPS Before Extra, 2 Yr. CAGR %	908.48	296.06	31.49	-27.24	-47.78
Accounts Receivable, 2 Yr. CAGR %	50.98	22.4	-57.5	4.42	452.75
Net Property, Plant and Equip., 2 Yr. CAGR %	-6.19	-12.28	-48.23	-31.4	16.68
Total Assets, 2 Yr. CAGR %	63.84	42.86	-6.09	65.87	130.38
Tangible Book Value, 2 Yr. CAGR %	72.05	326.01	48.66	81.82	158.92
Common Equity, 2 Yr. CAGR %	261.8	916.31	-32.82	132.93	213.02
Cash From Operations, 2 Yr. CAGR %	48.63	40.6	23.34	64.63	34.11
Capital Expenditures, 2 Yr. CAGR %	161.3	91.59	-71.85	-44.18	234.17
Levered Free Cash Flow, 2 Yr. CAGR %	74.71	-4.96	5.93	62.19	68.93
Unlevered Free Cash Flow, 2 Yr. CAGR %	48.19	-16.03	-3.82	-6.12	33.89
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2	4.76	-42.54	-6.59	115.14
Gross Profit, 3 Yr. CAGR %	29.39	32.9	-54.01	4.87	149.02
EBITDA, 3 Yr. CAGR %	139.61	157.06	66.98	22.6	7.18
EBITA, 3 Yr. CAGR %	116.85	129.71	62.28	22.03	7.27
EBIT, 3 Yr. CAGR %	117.23	131.12	64.78	22.75	13.88
Earnings From Cont. Operations, 3 Yr. CAGR %	300.4	457.53	215.13	20.84	29.06
Net Income, 3 Yr. CAGR %	308.94	457.02	213.14	18.83	30.73
Normalized Net Income, 3 Yr. CAGR %	362.77	1.05K	63.33	22.51	19.98
Diluted EPS Before Extra, 3 Yr. CAGR %	-	408.1	176.02	-15.99	-25.05
Accounts Receivable, 3 Yr. CAGR %	25.53	25.94	-32.4	-1.51	84.68
Net Property, Plant and Equip., 3 Yr. CAGR %	-7.42	-12.95	-34.97	-29.34	-21.34
Total Assets, 3 Yr. CAGR %	34.12	26.23	33.92	27.27	84.16
Tangible Book Value, 3 Yr. CAGR %	41.88	72.52	184.88	79	104.4
Common Equity, 3 Yr. CAGR %	131.41	76.51	380.54	31.61	119.16
Cash From Operations, 3 Yr. CAGR %	24.69	37.46	36.75	47.16	32.51
Capital Expenditures, 3 Yr. CAGR %	63.09	36.75	-8.09	-52.2	36.15
Levered Free Cash Flow, 3 Yr. CAGR %	-	25.95	15.69	-18.99	146.56
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	10.84	1.7	-54.83	137.46
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	4.1	-30.48	-3.38	21.89
Gross Profit, 5 Yr. CAGR %	-	19.05	-28.92	19.58	34.69
EBITDA, 5 Yr. CAGR %	-	78.21	67.02	93.92	42.85
EBITA, 5 Yr. CAGR %	-	67.61	57.38	80.85	40.48
EBIT, 5 Yr. CAGR %	-	68.7	58.3	81.64	46.89
Earnings From Cont. Operations, 5 Yr. CAGR %	-	401.33	165.83	195.85	107.09
Net Income, 5 Yr. CAGR %	-	494.3	167.86	192.88	114.85
Normalized Net Income, 5 Yr. CAGR %	-	467.4	152.39	373.03	49.44
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	127.02	41.81
Accounts Receivable, 5 Yr. CAGR %	-	-	-18.6	16.84	56.66
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-26.63	-20.86	-17.84
Total Assets, 5 Yr. CAGR %	-	-	16.3	40.8	66.37
Tangible Book Value, 5 Yr. CAGR %	-	-	44.55	76.18	174.2
Common Equity, 5 Yr. CAGR %	-	-	41.1	97.22	304.82
Cash From Operations, 5 Yr. CAGR %	-	18.92	24.15	47.74	35.69
Capital Expenditures, 5 Yr. CAGR %	-	-3.95	-19.23	-5.69	54.03
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	10.17	33.12
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-27.35	9.75